Esther Rajavelu
Stock Analyst at UBS
(1.20)
# 3,586
Out of 4,893 analysts
26
Total ratings
46.67%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $331 → $349 | $320.87 | +8.77% | 6 | May 2, 2025 | |
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.40 | +406.33% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $15.00 | +113.33% | 2 | Apr 9, 2024 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $41.44 | +76.16% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $14.48 | +652.76% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $12.02 | +191.18% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $42.83 | -12.44% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $111.60 | +104.30% | 1 | Mar 1, 2021 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $18.88 | - | 1 | Dec 13, 2019 | |
| INVA Innoviva | Initiates: Hold | $13 | $19.17 | -32.19% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.22 | +719.67% | 1 | Jul 21, 2017 |
Alnylam Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $331 → $349
Current: $320.87
Upside: +8.77%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.40
Upside: +406.33%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $15.00
Upside: +113.33%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $41.44
Upside: +76.16%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $14.48
Upside: +652.76%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $12.02
Upside: +191.18%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $42.83
Upside: -12.44%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $111.60
Upside: +104.30%
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $18.88
Upside: -
Innoviva
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $19.17
Upside: -32.19%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.22
Upside: +719.67%